15. October 2016

Objectives The aim of this work was to investigate the use of liquisolid technique to sustain the release of a model highly soluble drug, diltiazem HCl, from liquisolid matrices containing Polyox, a recently proposed matrix-forming hydrophilic polymer as an alternative to hypromellose. Methods Polyox-based liquisolid formulations prepared using several non-volatile solvents (i.e. polysorbate 80, polyethylene glycol, polyethylene glycol 200 and polyethylene glycol 600) and then characterised...

20. July 2016

Abstract Objective: A novel multiparticulate system for the gastric delivery of Diltiazem (DTZ) was developed for effective treatment of hypertension. Materials and methods: Floating microspheres of ethylcellulose and Eudragit loaded with DTZ were successfully developed and evaluated for their gastro-retentive and controlled-release properties. The effect of various process variables on the particle morphology, micromeritic properties, in vitro floating behavior, percentage drug entrapment, and...

18. February 2016

Polyethylene oxide (PEO) has been extensively used as an extended-release excipient in matrix tablets due to its extraordinarily safe, stable, soluble, swellable and erodible properties. The present study aimed to develop once-daily sustained-release tablets using PEO for a highly water-soluble drug, diltiazem hydrochloride (DH), the clinical application of which is limited because of its short half-life in vivo. However, the prophase study demonstrated that the use of PEO alone could only...